multiple organ dysfunction syndrome
multiple organ dysfunction syndrome
Explore linked clinical trials. Standard reference: MONDO:004372639 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| pSOFA Score in Predicting Mortality in Pediatric Intensive Care | Critical Illness, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, multiple organ dysfunction syndrome | Not yet recruiting | Not stated | 2026-10-05 | NCT07858487 | |
| Prognostic Value of Stress Hyperglycemia Ratio in Critically Ill Patients | Critical Illness, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, Urogenital Diseases, acute kidney injury, glucose metabolism disease, hyperglycemia, kidney disorder, kidney failure, metabolic disease, multiple organ dysfunction syndrome, urinary system disorder | Not yet recruiting | Not stated | 2026-10-02 | NCT07853911 | |
| FOUR-Based Modification of ICU Severity Scores | Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, multiple organ dysfunction syndrome | Not yet recruiting | Not stated | 2026-09-22 | NCT07832773 | |
| Metabolic and Functional Study of γδ T Cells in Critically Ill Patients | Critical Illness, Disease Attributes, Dysbiosis, Infections, Inflammation, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, inborn mitochondrial metabolism disorder, metabolic disease, multiple organ dysfunction syndrome | Recruiting | Not stated | 2026-09-17 | NCT07680816 | |
| Efferon LPS Hemoadsorption in Cardiac Surgery Patients | Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, cardiovascular disorder, heart disorder, multiple organ dysfunction syndrome | Recruiting | Not applicable | 2026-08-26 | NCT07532174 | |
| AI-Based Precision Transfusion Prediction Model in Critically Ill Patients | Critical Illness, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, multiple organ dysfunction syndrome | Not yet recruiting | Not stated | 2026-08-13 | NCT07762131 | |
| Impact of Metabolite Supplementation to Restore Mitochondrial Dysfunction During Septic Shock: a Preclinical Study | Infections, Inflammation, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, inborn mitochondrial metabolism disorder, metabolic disease, multiple organ dysfunction syndrome, toxic shock syndrome | Recruiting | Not stated | 2026-08-10 | NCT04288635 | |
| Hemoadsorpion in Patients With Septic Shock: Efficacy and Safety Evaluation | Endotoxemia, Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, Toxemia, bacterial infectious disease with sepsis, multiple organ dysfunction syndrome, toxic shock syndrome | Not yet recruiting | Not applicable | 2026-07-02 | NCT07661303 | |
| Trial of Indication-Based Transfusion of Red Blood Cells in ECMO | Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, multiple organ dysfunction syndrome | Active, not recruiting | Not applicable | 2026-07-02 | NCT05405426 | |
| Evaluating the Utility of RELiZORB™ for Treating Feeding Intolerance in Critically Ill Adults With Multi-Organ Failure | Digestive System Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, exocrine pancreatic insufficiency, multiple organ dysfunction syndrome, pancreas disorder | Active, not recruiting | Not applicable | 2026-07-01 | NCT05710315 | |
| ICU Background Early Awareness for Critical deterioratiON | Pathologic Processes, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Shock, multiple organ dysfunction syndrome, respiratory failure, respiratory system disorder | Recruiting | Not stated | 2026-06-15 | NCT07119411 | |
| Adding a Gastrointestinal Subscore to SOFA2 for Mortality Risk Assessment in the ICU: The SOFA2-GIS Study | Critical Illness, Digestive System Diseases, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, digestive system disorder, multiple organ dysfunction syndrome | Not yet recruiting | Not stated | 2026-05-26 | NCT07586254 | |
| Heterogeneity of Critical Illness: a Cohort Study | Critical Illness, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, multiple organ dysfunction syndrome | Recruiting | Not stated | 2026-05-26 | NCT04502511 | |
| Artificial Intelligence for Ulinastatin Responder Outcome & Risk Assessment in CPB | Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Shock, Systemic Inflammatory Response Syndrome, multiple organ dysfunction syndrome | Active, not recruiting | Not stated | 2026-05-13 | NCT07583290 | |
| COVID-19 Outcome Prediction Algorithm | COVID-19, Chronic Disease, Coronaviridae Infections, Disease Attributes, Frailty, Frailty Syndrome, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, RNA Virus Infections, Shock, long COVID-19, lung disorder, multiple organ dysfunction syndrome, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Active, not recruiting | Not stated | 2026-04-24 | NCT05471011 | |
| Effect of oXiris Hemofilter Use in Septic Shock: A Multicenter Retrospective Cohort Study | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, multiple organ dysfunction syndrome, toxic shock syndrome | Recruiting | Not stated | 2026-04-20 | NCT07539883 | |
| Actualities in Procedural Sedation: Remimazolam | Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, multiple organ dysfunction syndrome | Active, not recruiting | Phase 4 | 2026-03-25 | NCT07362173 | |
| Sepsis in the ICU-II | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, cardiomyopathy, cardiovascular disorder, heart disorder, multiple organ dysfunction syndrome, toxic shock syndrome | Active, not recruiting | Not stated | 2026-03-17 | NCT04695119 | |
| Surgical Critical Care Initiative (SC2i) Tissue and Data Acquisition Protocol (TDAP) in Burn Patients Improving the Robustness and Generalizability of Post-burn Sepsis Prediction With the Post-Burn Sepsis Digital Twin. Group 1 | Critical Illness, Disease Attributes, Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Sepsis, Shock, Systemic Inflammatory Response Syndrome, adult acute respiratory distress syndrome, burn, injury, lung disorder, multiple organ dysfunction syndrome, respiratory system disorder | Not yet recruiting | Not stated | 2026-02-04 | NCT07249762 | |
| TDAP in Burn Patients (Group 2) | Critical Illness, Disease Attributes, Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Sepsis, Shock, Systemic Inflammatory Response Syndrome, adult acute respiratory distress syndrome, burn, injury, lung disorder, multiple organ dysfunction syndrome, respiratory system disorder | Not yet recruiting | Not stated | 2026-02-04 | NCT07223684 | |
| Early Continuous Renal Replacement Therapy for Pediatric Septic Shock | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, multiple organ dysfunction syndrome, toxic shock syndrome | Active, not recruiting | Not stated | 2026-01-27 | NCT07370753 | |
| Mechanisms of Prognostic Regulation andPrecision Phenotype Ldentification in Severe Infections Driven by SpecializedPro-Resolving Mediators | Critical Illness, Disease Attributes, Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, multiple organ dysfunction syndrome | Not yet recruiting | Not stated | 2026-01-21 | NCT07353970 | |
| Extracorporeal Blood Purification Using Oxiris for Septic Shock (EXPLORE Study) | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, multiple organ dysfunction syndrome, toxic shock syndrome | Not yet recruiting | Not applicable | 2026-01-14 | NCT07334327 | |
| Point-of-Care AI Assistance and Critical Care Outcomes: A Randomized Trial | Confusion, Critical Illness, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Infections, Inflammation, Male Urogenital Diseases, Neurobehavioral Manifestations, Neurologic Manifestations, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Signs and Symptoms, Systemic Inflammatory Response Syndrome, Urogenital Diseases, acute kidney injury, kidney disorder, kidney failure, multiple organ dysfunction syndrome, nervous system disorder, urinary system disorder | Not yet recruiting | Phase 1 / Phase 2 | 2025-12-18 | NCT07293078 | |
| Sivelestat Treatment for Postoperative Organ Protection in Type A Aortic Dissection | Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, multiple organ dysfunction syndrome | Not yet recruiting | Phase 4 | 2025-09-05 | NCT07156656 |